Skip to main content
Equibles

CITADEL ADVISORS LLC

Position in RVTY — Revvity, Inc.

CIK 1423053 MIAMI, FL
Back to RVTY Full portfolio

Position in RVTY

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$5,489,029
-$6,640,808 QoQ
Shares Held
62,653
-50.0% QoQ
Ownership
0.056%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Common Shares in RVTY Over Time

Shares Held

Position Value (USD)

Derivatives in RVTY

reported options exposure · as of Mar 31, 2026
CallValue
$420,528
CallShares
4,800
PutValue
$13,246,632
PutShares
151,200

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Diagnostics & Research

Healthcare · as of Mar 31, 2026

CITADEL ADVISORS LLC holds $1,657,068,556 across 34 Diagnostics & Research names. RVTY ranks #18 (0.3% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 TMO
Thermo Fisher Scientific Inc.
 864,489 $424,922,277
2 CRL
Charles River Laboratories International, Inc.
 1,212,152 $209,096,220
3 A
Agilent Technologies, Inc.
 1,801,714 $205,359,361
4 DHR
Danaher Corp /De/
 1,026,347 $194,595,390
5 MTD
Mettler Toledo International Inc/
 58,054 $73,217,704
6 GH
Guardant Health, Inc.
 775,941 $71,673,669
7 DGX
Quest Diagnostics Inc
 347,218 $68,047,783
8 IQV
Iqvia Holdings Inc.
 390,042 $66,517,762

All Filings in RVTY

Export CSV
50 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $420,528 4,800
2026-03-31 $13,246,632 151,200
2026-03-31 $5,489,029 62,653
2025-12-31 $12,129,837 125,373
2025-12-31 $986,850 10,200
2025-12-31 $406,350 4,200
2025-09-30 $447,015 5,100
2025-09-30 $2,423,697 27,652
2025-09-30 $482,075 5,500
2025-06-30 $444,912 4,600
2025-06-30 $860,808 8,900
2025-06-30 $1,245,946 12,882
2025-03-31 $317,400 3,000
2025-03-31 $380,880 3,600
2024-12-31 $424,118 3,800
2024-12-31 $401,796 3,600
2024-12-31 $455,480 4,081
2024-09-30 $1,085,875 8,500
2024-09-30 $638,750 5,000
2024-06-30 $51,340,504 489,610
2024-06-30 $870,338 8,300
2024-06-30 $681,590 6,500
2024-03-31 $2,593,500 24,700
2024-03-31 $69,772,395 664,499
2024-03-31 $2,436,000 23,200
2023-12-31 $863,549 7,900
2023-12-31 $77,326,002 707,401
2023-12-31 $2,579,716 23,600
2023-09-30 $785,970 7,100
2023-09-30 $156,463,932 1,413,405
2023-09-30 $1,527,660 13,800
2023-06-30 $3,088,540 26,000
2023-06-30 $166,306 1,400
2023-06-30 $89,372,606 752,358
2023-03-31 $417,113,927 3,130,076
2023-03-31 $1,705,728 12,800
2023-03-31 $346,476 2,600
2022-12-31 $1,318,068 9,400
2022-12-31 $1,444,266 10,300
2022-12-31 $179,484,123 1,280,018
2022-09-30 $1,431,927 11,900
2022-09-30 $17,838,199 148,244
2022-09-30 $1,648,521 13,700
2022-06-30 $711,100 5,000
2022-06-30 $5,091,476 35,800
2022-03-31 $933,535 5,351
2022-03-31 $4,344,054 24,900
2022-03-31 $5,390,814 30,900
2021-12-31 $6,815,934 33,900
2021-12-31 $4,765,122 23,700

Report a Problem

Category
Description
Email (optional, for follow-up)